To investigate the expression of interleukin-23(IL-23) and interleukin-17(IL-17) axis in the nasal polyp patients and explore the role of IL-23/IL-17 axis in the nasal polyp. Method〖WTBZ〗Forty-five nasal polyp(NP) patients’s NP tissue and 30 simple deviation of nasal septum patients’ normal inferior turbinate tissue were collected. mRNA and protein expression of IL-23 and IL-17 were detected by immunohistochemistry and RT-PCR. SPSS 17.0 software package was used for statistical analysis. test and Spearman coefficient were used to analyse and compare the expression level and the correlation．Results〖WTBZ〗RT-PCR demomstrated that the average expression level of IL-23p19mRNA and IL-17mRNA in NP tissues ［(0.676±0.077）,（0.681±0.044)］ had significant differences (P<0.01) from those in normal inferior turbinate tissues ［(0.212±0.015）, （0.220±0.044)］. Immunohistochemical staining demomstrated that there were much more IL-23 and IL-17 positive cells in NP patients than in the normal controls.The average expression levels of IL-23 and IL-17 protein in NP tissues ［(0.321±0.023）, （0.315±0.023)］ were significantly different (P<0.01) from those in normal inferior turbinate tissues ［(0.199±0.011）, （0.211±0.029)］. IL-17mRNA positively correlated with IL-23p19mRNA(r=0.723,P<0.01),and IL-17 protein positively correlated with IL-23 protein(r=0.991,P<0.01). Conclusion〖WTBZ〗IL-23 and IL-17 may involved in the chronic inflammation of NP.IL-23 may be play a role through adjusting the level of IL-17.
Key words
interleukin-23 /
interleukin-17 /
chronic rhinosinustitis /
nasal polyp /
immunohistochemistry /
RT-PCR
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 姜晓丹,李琳,朱冬冬.2010年同一气道 同一疾病国际论坛纪要［J］.中华耳鼻咽喉头颈外科杂志,2010，45（12）:1049-1050.
［2］Ivanov S,Bozinovski S,Bossios A,et al.Functional relevance of the IL-23/IL-17 axis in lnugs invivo ［J］.Am J Resoir Cell Mol Biol,2007,36(4):442-451.
［3］Kikly K,Liu L,Na S,et al.The IL-23/Th(17)axis:therapeutic targets for autoimmrne inflammation ［J］.Curr Opin Immunol,2006,18(6):670-675.
［4］中华医学会耳鼻咽喉科学分会，中华耳鼻咽喉科杂志编辑委员会.慢性鼻窦炎鼻息肉临床分型分期及内窥镜鼻窦手术疗效评定标准（1997年.海口）［J］.中华耳鼻咽喉科杂志,1998,33(3)：134.
［5］丁国臣，王亚辉，司迎，等.IL-23在鼻息肉中的表达及意义［J］.武警医学,2012,23(11)：976-978.
［6］Wang Y H，Lu Y J．The IL-17 cytokine family and their role in allergic inflammation［J］.Curr Opin Immunol，2008，20(6)：697-702．
［7］Voo K S，Wang Y H，Santori F R, et al．Identification of IL-17 producing FOXP3(+) regulatory T cells in humans［J］．Proc Natl Acad Sci U S A，2009，106(12)：4793-4798．
［8］Chen Y S，Arab S F．Westhofen M, et al．Expression of intedeukin-5，interleukin-8,and interleukiu-10 mRNA in the ostecmeatal complex in nasal polypnsis［J］．Am J Bhinol，2005，19(2)：117-123．
［9］Hamilos D L，Leung D Y，Huston D P，et al．GM-CSF，IL-5 and RANTES immunoreaetivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis［J］．Clin Exp Allergy，998,28(9)：1145-1152．
［10］Oppmann B,Lesley R B ,Blom J C,et al.Novel p19 protein engages IL-12p40 to form a cytokine,IL-23,with biological activities similar as well as distinct from IL-12［J］.Immunity,2000,13:715-725.
［11］Li J,Gran B,Zhang GX,et al.Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia［J］.J Neurol Sci,2003,215(1-2):95-103.
［12］Lubberts E,Koenders M I,van den Berg W B.The role of T-cell interleukin-17 in comducting destructive arthritis:lessons from animal models ［J］.Arthritis Res Ther,2005,7(1):29-37.
［13］Fuss I J,Becker C,Yang Z,et al.Both IL-12p70 and IL-23 are synthesized during active Crohn’s disease and are down-regulated by treatment with anti-IL-12p40 monoclonal antibody［J］.Inflamm Bowel Dis,2006,12(1):9-15.
［14］Yuan X,Hu J,Belladona M L,et al.Interleukin-23-expressing bone matrowderived neural stem-like cells exhibit antitumor activity against intracranial glioma［J］.Cancer Res,2006,66(5):2630-2638.
［15］Dewald G,Bork K.Missense mutations in the coagulation factor Ⅻ（Hageman factor） gene in hereditary angioedema with mormal Cl inhibitor［J］.Biochem Biophys Res Commun,2006,343(4):1286-1289.
［16］Schnyder-Candrian S, Togbe D, Couillin I, et al. Interleukin-17 is a negative regulator of established allergic asthma［J］. Exp Med, 2006,203:2715-2725.
PDF(1031 KB)
